149 related articles for article (PubMed ID: 24300951)
1. Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.
Florea F; Bernards C; Caproni M; Kleindienst J; Hashimoto T; Koch M; Sitaru C
Am J Pathol; 2014 Feb; 184(2):494-506. PubMed ID: 24300951
[TBL] [Abstract][Full Text] [Related]
2. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
[TBL] [Abstract][Full Text] [Related]
4. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
5. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
6. A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading.
Monshi B; Groth S; Richter L; Schmidt E; Zillikens D; Rappersberger K
Br J Dermatol; 2012 Nov; 167(5):1179-83. PubMed ID: 22639938
[TBL] [Abstract][Full Text] [Related]
7. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
8. N-linked glycosylation on laminin γ1 influences recognition of anti-laminin γ1 pemphigoid autoantibodies.
Li X; Qian H; Takizawa M; Koga H; Tsuchisaka A; Ishii N; Hayakawa T; Ohara K; Sitaru C; Zillikens D; Sekiguchi K; Hirako Y; Hashimoto T
J Dermatol Sci; 2015 Feb; 77(2):125-9. PubMed ID: 25600662
[No Abstract] [Full Text] [Related]
9. Anti-laminin gamma-1 pemphigoid.
Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
[TBL] [Abstract][Full Text] [Related]
10. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
11. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
12. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis.
Solimani F; Pollmann R; Ishii N; Eming R; Hashimoto T; Schmidt T; Hertl M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):735-741. PubMed ID: 29972879
[TBL] [Abstract][Full Text] [Related]
14. Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.
Kamata M; Fujita H; Hamanaka T; Takahashi K; Koga H; Hashimoto T; Sato S
JAMA Dermatol; 2013 Dec; 149(12):1437-9. PubMed ID: 24154702
[No Abstract] [Full Text] [Related]
15. Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice?
Sesarman A; Oswald E; Chiriac MT; Csorba K; Vuta V; Feldrihan V; Baican A; Bruckner-Tuderman L; Sitaru C
Immunol Lett; 2012 Mar; 143(1):92-100. PubMed ID: 22305931
[TBL] [Abstract][Full Text] [Related]
16. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
J Dermatol; 2024 Jun; 51(6):869-872. PubMed ID: 38214494
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis.
Peutz-Kootstra CJ; Hansen K; De Heer E; Abrass CK; Bruijn JA
J Pathol; 2000 Nov; 192(3):404-12. PubMed ID: 11054725
[TBL] [Abstract][Full Text] [Related]
18. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
19. Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice.
Lazarova Z; Hsu R; Briggaman RA; Yancey KB
Clin Immunol; 2000 Apr; 95(1 Pt 1):26-32. PubMed ID: 10794429
[TBL] [Abstract][Full Text] [Related]
20. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]